Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Corifollitropin Alfa 150 Μg

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07891793Not ApplicableCompletedPrimary

Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

NCT07240779Not ApplicableNot Yet RecruitingPrimary

Advanced Sperm Selection in ICSI: A Comparative Study of PICSI and ZyMot

Showing all 2 trials

Research Network

Common Treatments

  • Corifollitropin Alfa 150 Μg1
  • Gnrh Antagonist1
  • Picsi Dish1
  • Progesterone1
  • Human Menopausal Gonadotropin Hmg1

Active Sponsors

  • Assisting Nature1
  • Sunrise Fertility Center1

Activity Timeline